ARGX

Q: What is the price of argenx (ARGX) today?

The current price of argenx (ARGX) is $ 811.09, representing a 24.85% gain over the past year. The stock began the year trading around $ 840.95 and is currently priced at $ 811.09. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does argenx (ARGX) pay dividends?

argenx (ARGX) did not pay dividends over the past year.

Q: Is argenx (ARGX) a good investment?

argenx (ARGX) is currently trading at $ 811.09 with a P/E ratio of 37.60%. This represents a -570% premium compared to its historical average P/E. Over the past year, the stock has gained 24.85 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 24.85%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

argenx SE

Price

$ 811.09

return (12m)

24.85%

p/e

37.60

p/bv

6.63

DIVIDEND YIELD

0.00%

ARGX price

ARGX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ARGX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

8.66%

3 months

-4.77%

1 year

24.85%

2 years

105.98%

5 years

214.04%

10 years

0.00%

Fundamentals ARGX

review the fundamentals of argenx shares

P/E

37.60

Sector: -4.09 Industry: -4.09

P/S (PSR)

11.70

Sector: -3.87 Industry: -3.87

P/BV

6.63

Sector: 1.89 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

14.88%

Sector: -61.28% Industry: -61.28%

ROE

17.64%

Sector: -61.00% Industry: -61.00%

ROIC

50.61%

Sector: -2,142.55% Industry: -2,142.55%

NET MARGIN

31.12%

Sector: -39.07% Industry: -39.07%

GROSS MARGIN

89.14%

Sector: 37.83% Industry: 37.83%

OPERATING MARGIN

25.68%

Sector: -39.17% Industry: -39.17%

EV/EBITDA

37.87

Sector: -3.91 Industry: -3.91

EV/EBIT

37.87

Sector: -4.18 Industry: -4.18

PRICE-TO-ASSETS

5.59

Sector: 1.39 Industry: 1.39

BVPS

118.11

Sector: 1.88 Industry: 1.88

EPS

20.84

Sector: -2.04 Industry: -2.04

EQUITY-TO-ASSETS RATIO

0.84

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

0.16

Sector: 0.38 Industry: 0.38

CAGR REVENUE 5 YEARS

52.87%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF argenx ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 811.09

Fair Value

$ 0.00

Upside/Downside Return potential.

-70.99%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ARGX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.01	6.74	25.92%	2.29%	$ 547.30 B	21.83%
PFE	19.27	1.61	8.35%	6.53%	$ 149.71 B	12.42%
ABBV	100.54	0.00	0.00%	3.22%	$ 365.48 B	5.79%
NVO	12.44	6.41	51.50%	4.25%	$ 194.87 B	33.05%
MRK	31.01	0.00	0.00%	2.96%	$ 277.04 B	13.59%
AZN	27.54	6.04	21.93%	1.73%	$ 286.16 B	17.19%
GILD	19.21	7.23	37.62%	2.42%	$ 163.51 B	28.90%
BMY	16.31	0.00	0.00%	4.29%	$ 118.65 B	15.01%
ZTS	18.71	15.01	80.25%	1.78%	$ 50.00 B	28.23%
REGN	16.49	2.32	14.08%	0.51%	$ 72.95 B	29.65%
HALO	23.82	154.63	649.21%	0.00%	$ 7.55 B	22.69%
AMGN	22.83	19.38	84.87%	2.93%	$ 178.10 B	20.96%
MCK	23.07	-1,011.36	-4,383.84%	0.39%	$ 100.12 B	1.09%
VRTX	27.24	5.77	21.18%	0.00%	$ 107.68 B	32.94%
HRMY	11.43	2.08	18.24%	0.00%	$ 1.81 B	18.27%
CAH	29.51	-17.17	-58.20%	1.05%	$ 45.88 B	0.62%
ADMA	17.04	5.25	30.78%	0.00%	$ 2.50 B	28.80%
BIIB	20.04	1.47	7.36%	0.00%	$ 27.50 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

ARGX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT argenx

argenx SE

Average Investor10 user rating

4.0 (12 people)

United States

18 years

Founded: 2008

2017

Time since IPO - 9 years

336

Employees

argenx SE (United States) is listed on the Nasdaq and has a market capitalization of $48.58 Billions, with shareholders equity totaling $7.32 Billions.

The company employs approximately 336 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, argenx SE reported $4.15 Billions in revenue, generating net income of $1.29 Billion.

Key financial metrics include a P/E ratio of 37.60, a price-to-book (P/B) ratio of 6.63, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARGX.

Market cap

$ 48.58 Billions

Net worth

$ 7.32 Billions

$ 7,323,090,000.00

Assets

$ 8.68 Billions

$ 8,682,700,000.00

Total Shares Outstanding

62.00 Millions

62,000,000

Average Daily Trading Volume

$ 338.58 Thousand

$ 338,579.56

Sector

Health Care

Industry

Biotechnology

ARGX

ARGX revenue and profits

Financial Results ARGX

DRAG THE FRAME TO SEE MORE DATA

ARGX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 807.85 14,83% (12M)

P/E

23.07

0.39%

ROE

-4,383.84%

P/BV

-1,011.36

CAH - Cardinal Health

$ 197.06 31,12% (12M)

P/E

29.51

1.05%

ROE

-58.20%

P/BV

-17.17

JNJ - Johnson & Johnson

$ 224.20 49,56% (12M)

P/E

26.01

2.29%

ROE

25.92%

P/BV

6.74

PFE - Pfizer

$ 26.30 20,14% (12M)

P/E

19.27

6.53%

ROE

8.35%

P/BV

1.61

MRK - Merck & Co.

$ 113.11 41,50% (12M)

P/E

31.01

2.96%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 183.46 32,89% (12M)

P/E

27.54

1.73%

ROE

21.93%

P/BV

6.04

ABBV - AbbVie

$ 208.16 10,55% (12M)

P/E

100.54

3.22%

ROE

0.00%

P/BV

0.00

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 807.85 14,83% (12 M)

P/L

23.07

0.39%

ROE

-4,383.84%

P/VP

-1,011.36

CAH - Cardinal Health

$ 197.06 31,12% (12 M)

P/L

29.51

1.05%

ROE

-58.20%

P/VP

-17.17

JNJ - Johnson & Johnson

$ 224.20 49,56% (12 M)

P/L

26.01

2.29%

ROE

25.92%

P/VP

6.74

PFE - Pfizer

$ 26.30 20,14% (12 M)

P/L

19.27

6.53%

ROE

8.35%

P/VP

1.61

MRK - Merck & Co.

$ 113.11 41,50% (12 M)

P/L

31.01

2.96%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 183.46 32,89% (12 M)

P/L

27.54

1.73%

ROE

21.93%

P/VP

6.04

ABBV - AbbVie

$ 208.16 10,55% (12 M)

P/L

100.54

3.22%

ROE

0.00%

P/VP

0.00

Frequently Asked Questions

What is the price of argenx (ARGX) today?

The current price of argenx (ARGX) is $ 811.09, representing a 24.85% gain over the past year. The stock began the year trading around $ 840.95 and is currently priced at $ 811.09. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does argenx (ARGX) pay dividends?

argenx (ARGX) did not pay dividends over the past year.

Is argenx (ARGX) a good investment?

argenx (ARGX) is currently trading at $ 811.09 with a P/E ratio of 37.60%. This represents a -570% premium compared to its historical average P/E. Over the past year, the stock has gained 24.85 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 24.85%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy argenx (ARGX) stock?

You can buy argenx (ARGX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ARGX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of argenx (ARGX) yield today?

Over the past month, argenx (ARGX) has returned 8.66% — 24.85% over the past year, and 214.04% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of argenx (ARGX) today at the current price of $ 811.09 your total investment would be $ 81,109.00.

Based on historical performance, the investment would have grown to approximately:

$ 101,264.59 after 1 year
$ 254,714.70 after 5 years
$ 81,109.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARGX

argenx SE

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARGX

review the fundamentals of argenx shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

ABOUT argenx

argenx SE

United States

18 years

2017

336

PROFIT X PRICE ARGX

Financial Results ARGX

ARGX cash flow

Asset, Revenue and Profit Growth - ARGX

ARGX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

Frequently Asked Questions